PGNY Valuation
Progyny Inc
$
23.060
- Overview
- Forecast
- Valuation
- Earnings
PGNY Relative Valuation
PGNY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PGNY is overvalued; if below, it's undervalued.
Historical Valuation
Progyny Inc (PGNY) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 123.01. The fair price of Progyny Inc (PGNY) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 23.01 USD , Progyny Inc is Undervalued By Fair.
Relative Value
Fair Zone
+Inf-+Inf
Current Price：23.01
Fair
Undervalued
13.33
PE
1Y
3Y
5Y
Trailing
Forward
7.54
EV/EBITDA
Progyny Inc. (PGNY) has a current EV/EBITDA of 7.54. The 5-year average EV/EBITDA is 26.29. The thresholds are as follows: Strongly Undervalued below -11.17, Undervalued between -11.17 and 7.56, Fairly Valued between 45.03 and 7.56, Overvalued between 45.03 and 63.76, and Strongly Overvalued above 63.76. The current Forward EV/EBITDA of 7.54 falls within the Undervalued range.
7.72
EV/EBIT
Progyny Inc. (PGNY) has a current EV/EBIT of 7.72. The 5-year average EV/EBIT is 69.05. The thresholds are as follows: Strongly Undervalued below -152.01, Undervalued between -152.01 and -41.48, Fairly Valued between 179.58 and -41.48, Overvalued between 179.58 and 290.10, and Strongly Overvalued above 290.10. The current Forward EV/EBIT of 7.72 falls within the Historic Trend Line -Fairly Valued range.
1.46
PS
Progyny Inc. (PGNY) has a current PS of 1.46. The 5-year average PS is 4.00. The thresholds are as follows: Strongly Undervalued below -0.60, Undervalued between -0.60 and 1.70, Fairly Valued between 6.30 and 1.70, Overvalued between 6.30 and 8.60, and Strongly Overvalued above 8.60. The current Forward PS of 1.46 falls within the Undervalued range.
10.10
P/OCF
Progyny Inc. (PGNY) has a current P/OCF of 10.10. The 5-year average P/OCF is 35.18. The thresholds are as follows: Strongly Undervalued below -15.38, Undervalued between -15.38 and 9.90, Fairly Valued between 60.46 and 9.90, Overvalued between 60.46 and 85.74, and Strongly Overvalued above 85.74. The current Forward P/OCF of 10.10 falls within the Historic Trend Line -Fairly Valued range.
10.84
P/FCF
Progyny Inc. (PGNY) has a current P/FCF of 10.84. The 5-year average P/FCF is 36.67. The thresholds are as follows: Strongly Undervalued below -17.35, Undervalued between -17.35 and 9.66, Fairly Valued between 63.69 and 9.66, Overvalued between 63.69 and 90.70, and Strongly Overvalued above 90.70. The current Forward P/FCF of 10.84 falls within the Historic Trend Line -Fairly Valued range.
Progyny Inc (PGNY) has a current Price-to-Book (P/B) ratio of 3.61. Compared to its 3-year average P/B ratio of 6.35 , the current P/B ratio is approximately -43.23% higher. Relative to its 5-year average P/B ratio of 11.97, the current P/B ratio is about -69.87% higher. Progyny Inc (PGNY) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 6.14%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 3.90% , the current FCF yield is about -100.00% lower.
3.76
P/B
Median3y
6.35
Median5y
11.97
10.16
FCF Yield
Median3y
6.14
Median5y
3.90
Competitors Valuation Multiple
The average P/S ratio for PGNY's competitors is 1.11, providing a benchmark for relative valuation. Progyny Inc Corp (PGNY) exhibits a P/S ratio of 1.46, which is 31.09% above the industry average. Given its robust revenue growth of 9.47%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of PGNY decreased by 1.83% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 304.09M to 332.87M.
The secondary factor is the Margin Expansion, contributed -5.17%to the performance.
Overall, the performance of PGNY in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
OXLC
Oxford Lane Capital Corp
3.530
USD
-0.28%
MBIN
Merchants Bancorp
33.130
USD
+2.51%
ELPC
Companhia Paranaense de Energia
8.420
USD
+1.15%
AKRO
Akero Therapeutics Inc
48.310
USD
+0.58%
ROG
Rogers Corp
77.950
USD
+4.14%
CHCO
City Holding Co
124.400
USD
+1.02%
TARS
Tarsus Pharmaceuticals Inc
52.720
USD
+2.65%
GDYN
Grid Dynamics Holdings Inc
8.060
USD
+1.64%
SIMO
Silicon Motion Technology Corp
76.635
USD
-0.99%
GOGL
Golden Ocean Group Ltd
8.270
USD
-1.66%
FAQ
Is Progyny Inc (PGNY) currently overvalued or undervalued?
Progyny Inc (PGNY) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 123.01. The fair price of Progyny Inc (PGNY) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 23.01 USD , Progyny Inc is Undervalued By Fair .
What is Progyny Inc (PGNY) fair value?
How does PGNY's valuation metrics compare to the industry average?
What is the current P/B ratio for Progyny Inc (PGNY) as of Aug 14 2025?
What is the current FCF Yield for Progyny Inc (PGNY) as of Aug 14 2025?
What is the current Forward P/E ratio for Progyny Inc (PGNY) as of Aug 14 2025?